Pichon Maxime, Burucoa Christophe
Bacteriology and Infection Control Laboratory, Infectious Agents Department, University Hospital of Poitiers, 86021 Poitiers, France.
Laboratoire Inflammation, Tissus Épithéliaux et Cytokines, EA 4331, Faculté de Médecine et de Pharmacie, University of Poitiers, 86022 Poitiers, France.
Healthcare (Basel). 2019 Feb 22;7(1):34. doi: 10.3390/healthcare7010034.
is a bacterium that selectively infects the gastric epithelium of half of the world population. The microbiome, community of microorganisms gained major interest over the last years, due to its modification associated to health and disease states. Even if most of these descriptions have focused on chronic disorders, this review describes the impact of the intestinal bacterial microbiome on host response to associated diseases. Microbiome has a direct impact on host cells, major barrier of the gastro-intestinal tract, but also an indirect impact on immune system stimulation, by enhancing or decreasing non-specific or adaptive response. In microbial infections, especially in precancerous lesions induced by infection, these modifications could lead to different outcome. Associated to data focusing on the microbiome, transcriptomic analyses of the eukaryote response would lead to a complete understanding of these complex interactions and will allow to characterize innovative biomarkers and personalized therapies.
是一种选择性感染世界上一半人口胃上皮的细菌。微生物群,即微生物群落,在过去几年中引起了极大的关注,因为其与健康和疾病状态相关的改变。即使这些描述大多集中在慢性疾病上,但本综述描述了肠道细菌微生物群对宿主对相关疾病反应的影响。微生物群不仅对胃肠道的主要屏障宿主细胞有直接影响,还通过增强或降低非特异性或适应性反应对免疫系统刺激产生间接影响。在微生物感染中,尤其是在由感染引起的癌前病变中,这些改变可能导致不同的结果。结合关注微生物群的数据,对真核生物反应的转录组分析将有助于全面理解这些复杂的相互作用,并有助于鉴定创新的生物标志物和个性化疗法。